Consider drug efficacy before first-in-human trials

    loading  Checking for direct PDF access through Ovid

Abstract

Ethical review boards must focus on clinical promise as well as safety to hold the first tests of drugs in humans to a higher standard, say Jonathan Kimmelman and Carole Federico.

Related Topics

    loading  Loading Related Articles